Richard M. Sherry
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Virus-based gene therapy research, Cancer Research and Treatments
Most-Cited Works
- → Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes(2002)2,800 cited
- → A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer(2003)2,702 cited
- → Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes(2006)2,560 cited
- → Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy(2011)2,095 cited
- → Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma(2005)1,619 cited
- → Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor(2014)1,600 cited
- → Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1(2011)1,589 cited
- → Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma(2003)1,570 cited
- → B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells(2011)1,437 cited
- → Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen(2009)1,391 cited